VBLT NASDAQ
Vascular Biogenics Ltd.
1W: -34.2%
1M: -33.8%
3M: -44.2%
1Y: +13.0%
3Y: -87.6%
5Y: -89.2%
$0.16
Last traded 2023-10-16 — delisted
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Cash Flow Trends
Operating Cash Flow
-$32M
-26.5% ▼
Capital Expenditures
$812K
+44.6% ▲
5Y CAGR: -34.0%
Free Cash Flow
-$32M
-22.5% ▼
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$4M
-150.0% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$20M | -$19M | -$24M | -$30M | -$32M |
| Depreciation & Amort. | $1M | $2M | $1M | $1M | $1M |
| Stock-Based Comp. | $4M | $2M | $2M | $2M | $3M |
| Change in Working Capital | -$244K | $3M | -$2M | $2M | -$3M |
| Other Non-Cash Items | -$886K | -$747K | $231K | $13K | -$294K |
| Operating Cash Flow | -$16M | -$13M | -$23M | -$25M | -$32M |
| — Investing Activities — | |||||
| Capital Expenditures | -$2M | -$73K | -$51K | -$1M | -$812K |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | -$28M |
| Investment Purchases | -$21M | -$64M | -$41M | -$51M | -$3M |
| Investment Sales | $48M | $57M | $51M | $37M | $31M |
| Other Investing | $4K | $0 | $0 | $0 | $28M |
| Investing Cash Flow | $25M | -$7M | $10M | -$15M | $27M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | $0 | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $14M | -$757K | $17M | $49M | $22K |
| Financing Cash Flow | $14M | -$757K | $17M | $49M | $22K |
| Net Change in Cash | $23M | -$20M | $4M | $9M | -$4M |
| Cash End of Period | $29M | $9M | $14M | $22M | $18M |
| Free Cash Flow | -$18M | -$13M | -$23M | -$26M | -$32M |